Adaptive licensing and facilitated regulatory pathways: A survey of stakeholder perceptions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adaptive licensing and facilitated regulatory pathways: A survey of stakeholder perceptions

Published:2015-06-30 Issue:5 Volume:98 Page:477-479
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Liberti L¹²,Stolk P²,McAuslane N¹,Somauroo A¹,Breckenridge AM³,Leufkens HGM²

Affiliation:

1. Centre for Innovation in Regulatory Science (CIRS); London UK

2. Division of Pharmacoepidemiology and Clinical Pharmacology; Utrecht Institute for Pharmaceutical Sciences, Utrecht University; The Netherlands

3. Department of Pharmacology; School of Life Sciences; University of Liverpool; Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.140/fullpdf

Reference5 articles.

1. Accelerated access to innovative medicines for patients in need;Baird;Clin. Pharmacol. Ther,2014

2. A flexible blueprint for the future of drug development;Barker;Lancet,2010

3. Adaptive licensing: taking the next step in the evolution of drug approval;Eichler;Clin. Pharmacol. Ther,2012

4. From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients;Eichler;Clin. Pharmacol. Ther,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs;Molecular Therapy - Methods & Clinical Development;2021-06

2. Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars;Pharmaceuticals;2021-02-25

3. The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested Solutions;Pharmaceutical Medicine;2021-02-04

4. A Proposed Framework for a Globally Applicable Pragmatic Approach to Using Facilitated Regulatory Pathways;Therapeutic Innovation & Regulatory Science;2020-01

5. The Confluence of Accelerated Regulatory and Health Technology Assessment Access Pathways;Clinical Pharmacology & Therapeutics;2019-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3